Literature DB >> 22346380

Host defence to pulmonary mycosis.

C H Mody1, P W Warren.   

Abstract

OBJECTIVE: To provide a basic understanding of the mechanisms of host defense to pathogenic fungi. This will help physicians understand why some patients are predisposed to fungal infections and update basic scientists on how microbial immunology applies to fungal disease. DATA SOURCES: English articles from 1966 to present were identified from a MEDLINE search. STUDY SELECTION: Articles were identified by a MEDLINE search of 'exp lung/' or 'exp lung diseases/' and 'exp fungi/'. The titles and abstracts were screened to identify articles that contained salient information pertaining to host defense of respiratory mycoses. DATA EXTRACTION: Information was summarized from the articles pertaining to host defense of pulmonary mycosis that had been identified by the MEDLINE search. DATA SYNTHESIS: Fungi represent a unique and highly diverse group of pathogenic organisms that have become an increasingly prevalent cause of life-threatening illness. A worldwide increase in persons with immunodeficiency has been a major contributing factor to the increase in fungal disease. As a result, clinicians are faced with an expanding array of fungal infections that pose diagnostic and therapeutic challenges. The respiratory tract is the route of acquisition for many important fungal infections; thus, understanding the host defense in the lung is an essential component of understanding host defense to fungal disease. With this understanding, fungi may be divided on the basis of the predilection of certain mycosis for specific immune defects.
CONCLUSIONS: By separating fungi based on the host immune defects that predispose to disease, in conjunction with traditional divisions based on the geographic distribution of fungi, clinicians are able to focus their diagnostic efforts and to identify fungal pathogens better. In addition, an understanding of the normal host defense mechanisms that serve to control fungal infections is essential to the development of novel antifungal therapies.

Entities:  

Keywords:  AIDS; Fungi; Opportunistic infections; Pulmonary host defense

Year:  1999        PMID: 22346380      PMCID: PMC3250719          DOI: 10.1155/1999/139326

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  102 in total

1.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Current and future clinical applications of interferon-gamma in host antimicrobial defense.

Authors:  H W Murray
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus.

Authors:  T S Harrison; S M Levitz
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

4.  Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans.

Authors:  K Kawakami; X Qifeng; M Tohyama; M H Qureshi; A Saito
Journal:  Clin Exp Immunol       Date:  1996-12       Impact factor: 4.330

5.  Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.

Authors:  M X Zhang; B Klein
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 7.  Fungal infections: a growing threat.

Authors:  D M Dixon; M M McNeil; M L Cohen; B G Gellin; J R La Montagne
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

8.  Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS.

Authors:  A Vecchiarelli; C Monari; F Baldelli; D Pietrella; C Retini; C Tascini; D Francisci; F Bistoni
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

9.  Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes.

Authors:  R D Diamond; E Huber; C C Haudenschild
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

Review 10.  Fungal infections in solid-organ transplantation.

Authors:  C V Paya
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

View more
  2 in total

1.  A typical atypical pneumonia.

Authors:  J Mikhael; S Humphrey; M Jabi; Ad Badley
Journal:  Can J Infect Dis       Date:  2002-01

2.  Clinical characteristics and outcomes in patients with pulmonary blastomycosis.

Authors:  Doug Kralt; Bruce Light; Mary Cheang; Tracy MacNair; Lyle Wiebe; Bill Limerick; Pete Sarsfield; Greg Hammond; Kerry MacDonald; Elly Trepman; John M Embil
Journal:  Mycopathologia       Date:  2008-10-19       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.